Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TG4050 |
Trade Name | |
Synonyms | TG-4050|TG 4050 |
Drug Descriptions |
TG4050 is a vaccine consisting of modified Vaccinia virus Ankara (MVA) expressing tumor-specific neoantigens that may stimulate anti-tumor immune response (J Clin Oncol 40, no. 16_suppl (June 01, 2022) 2637). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C171392 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TG4050 | TG4050 | 0 | 2 |